HopeStage
Back to all studies
RecruitingNCT06919432

Repeated tACS stimulation for self-injury in adolescents

About this titleRead the official source — NCT06919432
Device studyAges 12–21ChinaSuicide prevention
The study in practice

Understand this study

Who could participate?

Listed age limits: 12 years to 21 years.

Listed locations
ShanghaiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
66
Sponsor
Shanghai Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
China
Age range
From 12 Years to 21 Years
Official registry ID
NCT06919432
Official title
Show the full official title

Efficacy of Triple-daily 15mA Transcranial Alternating Current Stimulation on Adolescent Non-suicidal Self-injury (NSSI): a Double-blind, Randomized, Sham-controlled Trial

Recruitment & locations

Currently recruiting

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.

Who can participate?

Listed age limits: 12 years to 21 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies